Abstract:Seven new compounds including four lanostane triterpenoids, lucidenic acids Q-S (1-3) and methyl ganoderate P (4), and three triterpene-farnesyl hydroquinone conjugates, ganolucinins A-C (5-7), one new natural product ganomycin J (8), and 73 known compounds (9-81) were isolated from fruiting bodies of Ganoderma lucidum. The structures of the compounds 1-8 were determined by spectroscopic methods. Bioactivities of compounds isolated were assayed against HMG-CoA reductase, aldose reductase, α-glucosidase, and PTP1B. Ganolucidic acid η (39), ganoderenic acid K (44), ganomycin J (8), and ganomycin B (61) showed strong inhibitory activity against HMG-CoA reductase with IC50 of 29.8, 16.5, 30.3 and 14.3μM, respectively. Lucidumol A (67) had relatively good effect against aldose reductase with IC50 of 19.1μM. Farnesyl hydroquinones ganomycin J (8), ganomycin B (61), ganomycin I (62), and triterpene-farnesyl hydroquinone conjugates ganoleuconin M (76) and ganoleuconin O (79) possessed good inhibitory activity against α-glucosidase with IC50 in the range of 7.8 to 21.5μM. This work provides chemical and biological evidence for the usage of extracts of G. lucidum as herbal medicine and food supplements for the control of hyperglycemic and hyperlipidemic symptoms.

Nor-triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH

Triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH

Lanostane triterpenoids from Ganoderma lucidum and their inhibitory effects against FAAH

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

New Lanostane-Type Triterpenoids from the Fruiting Body of Ganoderma Hainanense

Triterpenoids with neurotrophic activity from Ganoderma lucidum.

Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase

Lanostane triterpenoids from the fruiting bodies of Ganoderma amboinense

Cytotoxic lanostanoid triterpenes from Ganoderma lucidum.

New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum

Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe

Triterpenes from antler-shaped fruiting body of Ganoderma lucidum and their hepatoprotective activities

Lanostane triterpenoids with cytotoxic activities from the fruiting bodies of Ganoderma hainanense.

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum

Isolation of 3,4-Seco-27-norlanostane Triterpenoids from Cultivated Fruiting Bodies of Ganoderma Orbiforme

Meroterpenoids from the Fruiting Bodies of Ganoderma Ahmadii Steyaret and Their Protein Tyrosine Phosphatase 1B Inhibitory Activities

Cytotoxicity of Ganoderma Lucidum Triterpenes.

Lanostane Triterpenoids from the Fruiting Bodies of Fomes Officinalis and Their Anti-Inflammatory Activities

Lanostane triterpenoids with anti-proliferative and PTP1B/α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma calidophilum

Lanostanoids isolated from Ganoderma lucidum mycelium cultured by submerged fermentation

Minor ergosteroids and a 19- nor labdane-type diterpenoid with anti-inflammatory effects from Ganoderma lucidum